<DOC>
	<DOCNO>NCT00409942</DOCNO>
	<brief_summary>Torasemide loop diuretic ( pyridine-sulfonylurea ) wide experience treatment oedema associate heart failure , kidney liver disease either treatment arterial hypertension ( alone combine anti-hypertensive drug ) . It develop new formulation Torasemide ( Torasemide prolong release ) . The aim trial study effect Torasemide prolong release comparison furosemide , reduction myocardial fibrosis patient chronic heart failure ( Class II-IV New York Heart Association Classification .</brief_summary>
	<brief_title>Effect New Formulation Torasemide ( Prolonged Release ) Myocardial Fibrosis Patients With Heart Failure .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Torsemide</mesh_term>
	<criteria>Aged 18 Patients chronic heart failure class IIIV ( NYHA ) due arterial hypertension Patients clinically stable require diuretic treatment Patients leave ventricular hypertrophy diagnose echocardiogram Patients without ischaemic cardiopathy non recent disease Signed Informed Consent Heart Failure due aortic stenosis hypertrophic myocardiopathy Recent coronary syndrome ( le 3 month ) Recent myocardial infarction ( le 6 month ) Unstable angor pectoris Severe cardiac arrhythmia Pregnancy breastfeed Aldosterone antagonist ( last 6 month ) Current loop diuretic treatment study dos ( torasemide &gt; 10mg/day furosemide &gt; 40 mg/day ) know hypersensitivity study drug Liver disease ( SGPT AST &gt; twice upper normal limt ) Renal impairment ( Serum creatinine &gt; 2,5mg/dl ) Insulindependent diabetes Patient include another simultaneous study Lactose intolerance Lithium Concomitant treatment Chronic treatment NSAIDs Concomitant treatment aminoglycoside antibiotic , etacrynic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Chronic heart failure</keyword>
	<keyword>Torasemide prolonged release</keyword>
	<keyword>Myocardial fibrosis</keyword>
	<keyword>Loop diuretic</keyword>
	<keyword>Peptide procollagen type 1</keyword>
</DOC>